State Street Corp Heron Therapeutics, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 3,192,436 shares of HRTX stock, worth $3.89 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,192,436

Previous 5,280,866 39.55%

Holding current value

$3.89 Million

Previous $18.5 Million 65.63%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.73 - $3.67 $3.61 Million - $7.66 Million	-2,088,430 Reduced 39.55%	3,192,436 $6.35 Million
Q2 2024 Aug 14, 2024	BUY	$2.32 - $3.86 $6.59 Million - $11 Million	2,839,996 Added 116.35%	5,280,866 $18.5 Million
Q1 2024 May 15, 2024	SELL	$1.71 - $3.06 $70,067 - $125,383	-40,975 Reduced 1.65%	2,440,870 $6.76 Million
Q4 2023 Feb 14, 2024	BUY	$0.54 - $1.82 $43,352 - $146,115	80,283 Added 3.34%	2,481,845 $4.22 Million
Q3 2023 Nov 14, 2023	BUY	$0.97 - $1.8 $68,214 - $126,583	70,324 Added 3.02%	2,401,562 $2.47 Million
Q2 2023 Aug 14, 2023	SELL	$1.11 - $2.88 $249,478 - $647,294	-224,755 Reduced 8.79%	2,331,238 $2.7 Million
Q1 2023 May 15, 2023	SELL	$1.51 - $3.25 $46,717 - $100,551	-30,939 Reduced 1.2%	2,555,993 $3.86 Million
Q4 2022 Feb 14, 2023	SELL	$2.25 - $4.67 $14.1 Million - $29.2 Million	-6,251,774 Reduced 70.73%	2,586,932 $6.47 Million
Q3 2022 Nov 15, 2022	SELL	$2.66 - $5.37 $19.9 Million - $40.2 Million	-7,490,090 Reduced 45.87%	8,838,706 $37.3 Million
Q2 2022 Aug 15, 2022	BUY	$2.3 - $6.29 $7.83 Million - $21.4 Million	3,405,427 Added 26.35%	16,328,796 $45.6 Million
Q1 2022 May 16, 2022	BUY	$4.63 - $9.94 $24.2 Million - $52 Million	5,230,958 Added 68.0%	12,923,369 $73.9 Million
Q4 2021 Feb 14, 2022	BUY	$8.35 - $12.6 $10 Million - $15.1 Million	1,200,504 Added 18.49%	7,692,411 $70.2 Million
Q3 2021 Nov 15, 2021	BUY	$10.13 - $15.0 $18 Million - $26.7 Million	1,779,188 Added 37.75%	6,491,907 $69.4 Million
Q2 2021 Aug 16, 2021	BUY	$13.27 - $18.48 $1.7 Million - $2.37 Million	128,420 Added 2.8%	4,712,719 $73.1 Million
Q1 2021 May 17, 2021	BUY	$14.49 - $20.72 $8.73 Million - $12.5 Million	602,495 Added 15.13%	4,584,299 $74.3 Million
Q4 2020 Feb 16, 2021	SELL	$14.61 - $22.14 $6.26 Million - $9.49 Million	-428,430 Reduced 9.71%	3,981,804 $84.3 Million
Q3 2020 Nov 10, 2020	BUY	$13.67 - $17.77 $7.79 Million - $10.1 Million	569,776 Added 14.84%	4,410,234 $65.4 Million
Q2 2020 Aug 14, 2020	BUY	$10.89 - $21.47 $4.47 Million - $8.81 Million	410,333 Added 11.96%	3,840,458 $56.5 Million
Q1 2020 May 11, 2020	BUY	$10.23 - $24.56 $35.1 Million - $84.2 Million	3,430,125 New	3,430,125 $40.3 Million

Others Institutions Holding HRTX

# of Institutions

180

Shares Held

121M

Call Options Held

80.4K

Put Options Held

94.9K

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $145M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Heron Therapeutics, Inc. Transaction History